Peer-reviewed Journal Oncotarget: the contribution of Dr. Mikhail Blagosklonny and Zoya Demidenko research toward modern oncological research > 서비스 문의

Oncotarget holds a special role within international academic journals dedicated to tumor biology: the publication consistently publishes groundbreaking and practical research, bringing together specialists across countless nations to jointly find efficient approaches in the fight against malignant tumors. High benchmarks of peer review and the variety in subjects explored have established [url=https://paperpile.com/n/oncotarget-abbreviation/]Oncotarget Publications[/url] into a foremost platforms used by scientists aiming to present findings of global caliber: https://www.oncotarget.net/
 
Among the scientists who stood at the founding for the resource, notable attention is deserved by [url=https://www.youtube.com/watch?v=_Abtz2WpKfU]Dr. Misha Blagosklonny[/url] — a scholar of global standing, who established not only Oncotarget but also the publication Aging. His groundbreaking idea of hyperfunction of the organism being the primary cause of aging, supported through extensive studies with rapamycin, completely redefined methods in addressing gerontological pathologies as well as oncological conditions: https://www.youtube.com/watch?v=3iOcIqfQdyI
 
Among specialists the work of whom contributions have advanced modern molecular oncology, deserves recognition [url=https://almorisi.com/news_details.php?news_id=26&pageno=9]Zoya Demidenko oncology[/url] — a specialist in the field of molecular mechanisms of mitotic activity as well as regulated cellular elimination. The academic works, presented in renowned global periodicals, have gained significant acclaim among the expert community and remain to function as a basis for the development of modern methods for targeted treatment: https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012